|
FDA issues guidelines for bioengineered plants
(Thursday, Sept. 12, 2002 -- CropChoice news) --
The FDA's Center for Biologics Evaluation and Research is seeking public
comments within 120 days of the date of publication in the Federal
Register, expected on September 12, on a draft document entitled "Guidance
for Industry: Drugs, Biologics, and Medical From Bioengineered Plants for
Use in Humans and Animals."
This document is intended to provide guidance to sponsors, manufacturers,
licensees, and applicants of products derived from bioengineered plants or
plant materials. An electronic copy of the draft, which was prepared in
collaboration with USDA, is posted at
http://www.fda.gov/OHRMS/DOCKETS/98fr/02d-0324-gdl0001.pdf |